Clinical Research Directory
Browse clinical research sites, groups, and studies.
Addressing Involuntary Movements in Tardive Dyskinesia
Sponsor: Auspex Pharmaceuticals, Inc.
Summary
The purpose of this study is to determine whether fixed-doses of an investigational drug, SD-809 (deutetrabenazine), will reduce the severity of abnormal involuntary movements of tardive dyskinesia.
Official title: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
298
Start Date
2014-10-31
Completion Date
2016-08-19
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
SD-809
SD-809 tablets dose titrated for 4 weeks until target randomized dose is reached. The dose is maintained for an additional 8 weeks. Tablets were swallowed whole with water and taken with food.
Placebo
Placebo tablets taken twice daily for 12 weeks. Tablets were swallowed whole with water and taken with food.
Locations (106)
Teva Investigational Site 145
Tuscaloosa, Alabama, United States
Teva Investigational Site 107
Anaheim, California, United States
Teva Investigational Site 108
Anaheim, California, United States
Teva Investigational Site 123
Glendale, California, United States
Teva Investigational Site 177
Imperial, California, United States
Teva Investigational Site 160
Irvine, California, United States
Teva Investigational Site 106
Irvine, California, United States
Teva Investigational Site 176
Loma Linda, California, United States
Teva Investigational Site 121
Los Angeles, California, United States
Teva Investigational Site 147
Los Angeles, California, United States
Teva Investigational Site 174
Norwalk, California, United States
Teva Investigational Site 170
Oceanside, California, United States
Teva Investigational Site 102
Orange, California, United States
Teva Investigational Site 104
San Bernardino, California, United States
Teva Investigational Site 110
San Diego, California, United States
Teva Investigational Site 169
San Rafael, California, United States
Teva Investigational Site 129
Englewood, Colorado, United States
Teva Investigational Site 139
New Haven, Connecticut, United States
Teva Investigational Site 156
Washington D.C., District of Columbia, United States
Teva Investigational Site 157
Boca Raton, Florida, United States
Teva Investigational Site 117
Gainesville, Florida, United States
Teva Investigational Site 150
Lake City, Florida, United States
Teva Investigational Site 153
Miami, Florida, United States
Teva Investigational Site 162
Miami, Florida, United States
Teva Investigational Site 112
Orlando, Florida, United States
Teva Investigational Site 144
Port Charlotte, Florida, United States
Teva Investigational Site 155
Augusta, Georgia, United States
Teva Investigational Site 165
Decatur, Georgia, United States
Teva Investigational Site 131
Chicago, Illinois, United States
Teva Investigational Site 113
Chicago, Illinois, United States
Teva Investigational Site 164
Kansas City, Kansas, United States
Teva Investigational Site 154
Baltimore, Maryland, United States
Teva Investigational Site 101
Glen Burnie, Maryland, United States
Teva Investigational Site 135
Boston, Massachusetts, United States
Teva Investigational Site 118
Creve Coeur, Missouri, United States
Teva Investigational Site 142
Kansas City, Missouri, United States
Teva Investigational Site 175
St Louis, Missouri, United States
Teva Investigational Site 161
St Louis, Missouri, United States
Teva Investigational Site 178
Lincoln, Nebraska, United States
Teva Investigational Site 128
Albuquerque, New Mexico, United States
Teva Investigational Site 172
Commack, New York, United States
Teva Investigational Site 148
New York, New York, United States
Teva Investigational Site 138
Asheville, North Carolina, United States
Teva Investigational Site 146
Raleigh, North Carolina, United States
Teva Investigational Site 133
Charleston, South Carolina, United States
Teva Investigational Site 149
Memphis, Tennessee, United States
Teva Investigational Site 151
Fort Worth, Texas, United States
Teva Investigational Site 115
Salt Lake City, Utah, United States
Teva Investigational Site 141
Salt Lake City, Utah, United States
Teva Investigational Site 168
Burlington, Vermont, United States
Teva Investigational Site 171
Charlottesville, Virginia, United States
Teva Investigational Site 167
Richland, Washington, United States
Teva Investigational Site 166
Waukesha, Wisconsin, United States
Teva Investigational Site 559
Havířov, Czechia
Teva Investigational Site 556
Hostivice, Czechia
Teva Investigational Site 558
Hradec Králové, Czechia
Teva Investigational Site 535
Litoměřice, Czechia
Teva Investigational Site 557
Pilsen, Czechia
Teva Investigational Site 533
Prague, Czechia
Teva Investigational Site 532
Prague, Czechia
Teva Investigational Site 530
Prague, Czechia
Teva Investigational Site 531
Prague, Czechia
Teva Investigational Site 534
Prague, Czechia
Teva Investigational Site 502
Gera, Germany
Teva Investigational Site 503
Haag in Oberbayern, Germany
Teva Investigational Site 504
Mainz, Germany
Teva Investigational Site 507
Prien am Chiemsee, Germany
Teva Investigational Site 544
Taufkirchen, Germany
Teva Investigational Site 501
Wolfach, Germany
Teva Investigational Site 540
Balassagyarmat, Hungary
Teva Investigational Site 538
Budapest, Hungary
Teva Investigational Site 541
Budapest, Hungary
Teva Investigational Site 537
Budapest, Hungary
Teva Investigational Site 542
Budapest, Hungary
Teva Investigational Site 539
Doba, Hungary
Teva Investigational Site 546
Győr, Hungary
Teva Investigational Site 545
Kalocsa, Hungary
Teva Investigational Site 547
Szeged, Hungary
Teva Investigational Site 514
Bełchatów, Poland
Teva Investigational Site 554
Bialystok, Poland
Teva Investigational Site 510
Bydgoszcz, Poland
Teva Investigational Site 519
Bydgoszcz, Poland
Teva Investigational Site 536
Bydgoszcz, Poland
Teva Investigational Site 523
Chełmno, Poland
Teva Investigational Site 517
Choroszcz, Poland
Teva Investigational Site 513
Gdansk, Poland
Teva Investigational Site 512
Katowice, Poland
Teva Investigational Site 552
Katowice, Poland
Teva Investigational Site 520
Krakow, Poland
Teva Investigational Site 509
Krakow, Poland
Teva Investigational Site 508
Lodz, Poland
Teva Investigational Site 511
Lublin, Poland
Teva Investigational Site 515
Lublin, Poland
Teva Investigational Site 524
Lublin, Poland
Teva Investigational Site 549
Olsztyn, Poland
Teva Investigational Site 521
Pruszków, Poland
Teva Investigational Site 518
Sosnowiec, Poland
Teva Investigational Site 522
Torun, Poland
Teva Investigational Site 550
Warsaw, Poland
Teva Investigational Site 555
Warsaw, Poland